180 Life Sciences Corp. (NASDAQ: ATNF)
$1.5850
+0.0250 ( +1.60% ) 110.1K
180 Life Sciences Corp is a clinical-stage biotechnology company. It is focused on the development of therapeutics for unmet medical needs in chronic pain, inflammation and fibrosis by employing innovative research, and, where appropriate, combination therapy.
Market Data
Open
$1.5850
Previous close
$1.5600
Volume
110.1K
Market cap
$5.05M
Day range
$1.4960 - $1.6570
52 week range
$1.1600 - $17.7500
SEC Filings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 8-k/a | 8K-related | 14 | Jan 02, 2025 |
| 8-k | 8K-related | 14 | Dec 18, 2024 |
| 8-k | 8K-related | 15 | Dec 12, 2024 |
| 3 | Insider transactions | 1 | Dec 10, 2024 |
| 8-k | 8K-related | 17 | Dec 04, 2024 |
| 10-q | Quarterly Reports | 69 | Nov 14, 2024 |
| def | Proxies and info statements | 9 | Nov 12, 2024 |
| ars | Annual reports | 1 | Nov 12, 2024 |
| 8-k | 8K-related | 15 | Oct 31, 2024 |
| 8-k | 8K-related | 17 | Oct 29, 2024 |